Skip to contentE
Envoy Medical, Inc.
E
COCHEnvoy Medical, Inc. Q1 2025 · 10-Q
Revenue$46.00K$46.00K−22.0% vs Q1 2024 Net Income-$5.00M-$5.00MN/M vs Q1 2024 EPS Diluted-$0.29-$0.29N/M vs Q1 2024 Operating Income-$5,107,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
Free Cash Flowderived-$3,731,000N/M Margins · derivedOperating margin-11102.2%−2824.2 pt vs Q1 2024
Net margin-10865.2%−238.1 pt vs Q1 2024
ended Mar 31, 2025 · filed May 1, 2025 · 31 d after period end